Table of Contents
Journal of Theoretical Chemistry
Volume 2013 (2013), Article ID 768185, 13 pages
http://dx.doi.org/10.1155/2013/768185
Research Article

Scale Alpha and Beta of Quantitative Convergence and Chemical Reactivity Analysis in Dual Cholinesterase/Monoamine Oxidase Inhibitors for the Alzheimer Disease Treatment Using Density Functional Theory (DFT)

1Grupo de Química Cuántica y Teórica, Universidad de Cartagena, Programa de Química, Facultad de Ciencias Exactas y Naturales, 130015 Cartagena de Indias, Colombia
2Departamento de Ciencias Químicas, Universidad Nacional Andres Bello, República 275, 8370146 Santiago, Chile
3Corporación Universitaria Rafael Núñez, Facultad de Medicina, Cartagena, Colombia

Received 13 March 2013; Accepted 27 September 2013

Academic Editors: G. Borosky, Q. Ge, M. Koyama, A. M. Lamsabhi, N. Russo, and D. Sajan

Copyright © 2013 Alejandro Morales-Bayuelo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Goedert and M. G. Spillantini, “A century of Alzheimer's disease,” Science, vol. 314, pp. 777–781, 2006. View at Google Scholar
  2. C. Berchtold and C. W. Cotman, “Evolution in the conceptualization of Dementia and Alzheimer’s disease: greco-roman period to the 1960s,” Neurobiology of Aging, vol. 19, no. 3, pp. 173–189, 1998. View at Google Scholar
  3. D. K. Lahiri, M. R. Farlow, N. H. Greig, and K. Sambamurti, “Current drug targets for Alzheimer's disease treatment,” Drug Development Research, vol. 56, no. 3, pp. 267–281, 2002. View at Publisher · View at Google Scholar
  4. N. C. Inestrosa, M. C. Dinamarca, and A. Alvarez, “Amyloid-cholinesterase interactions implications for Alzheimer’s disease,” FEBS Journal, vol. 275, no. 4, pp. 625–632, 2008. View at Publisher · View at Google Scholar
  5. H. W. Querfurth and F. M. Laferla, “Alzheimer's disease,” The New England Journal of Medicine, vol. 362, pp. 329–344, 2010. View at Publisher · View at Google Scholar
  6. World Health Organization, Neurological Disorders Public Health Challenges, World Health Organization, Geneva, Switzerland, 2006.
  7. C. Geula and M.-M. Mesulam, “Cholinesterases and the pathology of Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 9, supplement 2, pp. 23–28, 1995. View at Google Scholar · View at Scopus
  8. M. Racchi, M. Mazzucchelli, E. Porrello, C. Lanni, and S. Govoni, “Acetylcholinesterase inhibitors: novel activities of old molecules,” Pharmacological Research, vol. 50, no. 4, pp. 441–451, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Clarke, E. Demont, C. Dingwall et al., “BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs),” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 3, pp. 1011–1016, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Gueto-Tettay, J. C. Drosos, and R. Vivas-Reyes, “Quantum mechanics study of the hydroxyethylamines-BACE-1 active site interaction energies,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 583–597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Beswick, N. Charrier, B. Clarke et al., “BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 3, pp. 1022–1026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Charrier, B. Clarke, L. Cutler et al., “Second generation of BACE-1 inhibitors. part 1: the need for improved pharmacokinetics,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 13, pp. 3664–3668, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Bolea, J. Juárez-Jiménez, C. de los Rios et al., “Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease,” Journal of Medicinal Chemistry, vol. 54, no. 24, pp. 8251–8270, 2011. View at Publisher · View at Google Scholar
  14. M. L. Bolognesi, R. Banzi, M. Bartolini et al., “Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease,” Journal of Medicinal Chemistry, vol. 50, no. 20, pp. 4882–4897, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. Bolognesi, A. Cavalli, L. Valgimigli et al., “Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer’s disease,” Journal of Medicinal Chemistry, vol. 50, no. 26, pp. 6446–6449, 2007. View at Publisher · View at Google Scholar
  16. M. Rosini, E. Simoni, M. Bartolini et al., “Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer’s disease: a promising direction for the multi-target-directed ligands gold rush,” Journal of Medicinal Chemistry, vol. 51, no. 15, pp. 4381–4384, 2008. View at Publisher · View at Google Scholar
  17. R. Carbó-Dorca, M. Arnau, and L. Leyda, “How similar is a molecule to another? An electron density measure of similarity between two molecular structures,” International Journal of Quantum Chemistry, vol. 17, no. 6, pp. 1185–1189, 1980. View at Publisher · View at Google Scholar
  18. R. Carbó-Dorca and L. D. Mercado, “Commentaries on quantum similarity (1): density gradient quantum similarity,” Journal of Computational Chemistry, vol. 31, no. 11, pp. 2195–2212, 2010. View at Publisher · View at Google Scholar
  19. X. Gironés and R. Carbó-Dorca, “Modelling toxicity using molecular quantum similarity measures,” QSAR & Combinatorial Science, vol. 25, no. 7, pp. 579–589, 2006. View at Publisher · View at Google Scholar
  20. R. Carbó-Dorca, E. Besalú, and L. D. Mercado, “Communications on quantum similarity, part 3: a geometric-quantum similarity molecular superposition algorithm,” Journal of Medicinal Chemistry, vol. 32, no. 4, pp. 582–599, 2011. View at Publisher · View at Google Scholar
  21. R. Carbó-Dorca and E. Besalú, “EMP as a similarity measure: a geometric point of view,” Journal of Mathematical Chemistry, vol. 51, no. 1, pp. 382–389, 2013. View at Publisher · View at Google Scholar
  22. R. Carbó-Dorca and X. Gironés, “Foundation of quantum similarity measures and their relationship to QSPR: density function structure, approximations, and application examples,” International Journal of Quantum Chemistry, vol. 101, no. 1, pp. 8–20, 2005. View at Publisher · View at Google Scholar
  23. R. Carbó-Dorca and E. Besalú, “Communications on quantum similarity (2): a geometric discussion on holographic electron density theorem and confined quantum similarity measures,” Journal of Computational Chemistry, vol. 31, no. 13, pp. 2452–2462, 2010. View at Publisher · View at Google Scholar
  24. L. Amat and R. Carbó-Dorca, “Use of promolecular ASA density functions as a general algorithm to obtain starting MO in SCF calculations,” International Journal of Quantum Chemistry, vol. 87, no. 2, pp. 59–67, 2002. View at Publisher · View at Google Scholar
  25. P. G. Mezey, Shape in Chemistry: An Introduction to Molecular Shape and Topology, Wiley-VCH, New York, NY, USA, 1993.
  26. R. G. Parr and W. Yang, Density Functional Theory of Atoms and Molecules, Oxford University Press, New York, NY, USA, 1989.
  27. P. W. Ayers, J. S. M. Anderson, and L. J. Bartolotti, “Perturbative perspectives on the chemical reaction prediction problem,” International Journal of Quantum Chemistry, vol. 101, no. 5, pp. 520–534, 2005. View at Publisher · View at Google Scholar
  28. J. L. Gazquez, “Perspectives on the density functional theory of chemical reactivity,” Journal of the Mexican Chemical Society, vol. 52, pp. 3–10, 2008. View at Google Scholar
  29. P. Geerlings, F. De Proft, and W. Langenaeker, “Conceptual density functional theory,” Chemical Reviews, vol. 103, no. 5, pp. 1793–1874, 2003. View at Publisher · View at Google Scholar
  30. W. Koch and M. C. Holthausen, A Chemist’s Guide to Density Functional Theory, Wiley-VCH, Weinheim, Germany, 2nd edition, 2000.
  31. R. Vivas-Reyes, F. De Proft, P. Geerlings et al., “A DFT and HF quantum chemical study of the tin nanocluster [(RSn)12O14OH6]2+  and its interactions with anions and neutral nucleophiles: confrontation with experimental data,” New Journal of Chemistry, vol. 9, pp. 1108–1117, 2002. View at Publisher · View at Google Scholar
  32. R. Mejia-Urueta, F. Nuñez-Zarur, and R. Vivas-Reyes, “Density functional study on electronic structures and reactivity in carbazol-oxadiazole dyads used in organic light emitting diodes,” International Journal of Quantum Chemistry, vol. 112, no. 16, pp. 2808–2815, 2012. View at Publisher · View at Google Scholar
  33. F. De Proft, R. Vivas-Reyes, M. Biesemans, R. Willem, J. M. L. Martin, and P. Geerlings, “Density functional study of the complexation reaction of Sn(CH3)3 X (X = F, Cl, Br and I) with halide anions,” European Journal of Inorganic Chemistry, vol. 2003, no. 20, pp. 3803–3810, 2003. View at Publisher · View at Google Scholar
  34. R. Vivas-Reyes, F. De Proft, M. Biesemans, R. Willem, and P. Geerlings, “A DFT study of Tin- and crown-ether-based host molecules capable of binding anions and cations simultaneously,” European Journal of Inorganic Chemistry, vol. 2003, no. 7, pp. 1315–1324, 2003. View at Publisher · View at Google Scholar
  35. A. Morales-Bayuelo, J. Torres, and R. Vivas-Reyes, “Quantum molecular similarity analysis and quantitative definition of catecholamines with respect to biogenic monoamines associated: scale alpha and beta of quantitative convergence,” International Journal of Quantum Chemistry, vol. 112, no. 14, pp. 2637–2642, 2012. View at Publisher · View at Google Scholar
  36. A. Morales-Bayuelo, J. Torres, and R. Vivas-Reyes, “Hückel treatment of pyrrole and pentalene as a function of cyclopentadienyle using local quantum similarity index (LQSI) and the topo-geometrical superposition approach (TGSA),” Journal of Theoretical and Computational Chemistry, vol. 11, article 223, 2012. View at Publisher · View at Google Scholar
  37. G. S. Hammond, “A correlation of reaction rates,” Journal of the American Chemical Society, vol. 77, no. 2, pp. 334–338.
  38. M. Duran and J. Beltran, “Potential energy hypersurfaces,” in Reports in Molecular Theory, vol. 1, p. 57, 1990. View at Google Scholar
  39. G. A. Arteca and P. G. Mezey, “Validity of the Hammond postulate and constraints on general one-dimensional reaction barriers,” Journal of Computational Chemistry, vol. 9, no. 7, pp. 728–744, 1988. View at Publisher · View at Google Scholar
  40. J. Cioslowski, “Quantifying the Hammond postulate: intramolecular proton transfer in substituted hydrogen catecholate anions,” Journal of the American Chemical Society, vol. 113, no. 18, pp. 6756–6760, 1991. View at Publisher · View at Google Scholar
  41. A. Morales-Bayuelo, H. Ayazo, and R. Vivas-Reyes, “Three-dimensional quantitative structure-activity relationship CoMSIA/CoMFA and LeapFrog studies on novel series of bicyclo [4.1.0] heptanes derivatives as melanin-concentrating hormone receptor R1 antagonists,” European Journal of Medicinal Chemistry, vol. 45, no. 10, pp. 4509–4522, 2010. View at Publisher · View at Google Scholar
  42. M. Ahumedo, A. Díaz, and R. Vivas-Reyes, “Theoretical and structural analysis of the active site of the transcriptional regulators LasR and TraR, using molecular docking methodology for identifying potential analogues of acyl homoserine lactones (AHLs) with anti-quorum sensing activity,” European Journal of Medicinal Chemistry, vol. 45, no. 2, pp. 608–615, 2010. View at Publisher · View at Google Scholar
  43. X. Gironés and R. Carbó-Dorca, “TGSA-Flex: extending the capabilities of the Topo-Geometrical superposition algorithm to handle flexible molecules,” Journal of Computational Chemistry, vol. 25, no. 2, pp. 153–159, 2003. View at Publisher · View at Google Scholar
  44. L. Chen, “Substructure and maximal common substructure searching,” in Computational Medicinal Chemistry for Drug Discovery, P. Bultinck, H. De Winter, W. Langenaeker, and J. P. Tollenaere, Eds., p. 483, Marcel Dekker, New York, NY, USA, 2003. View at Google Scholar
  45. J. P. Perdew, J. A. Chevary, S. H. Vosko et al., “Atoms, molecules, solids, and surfaces: applications of the generalized gradient approximation for exchange and correlation,” Physical Review B, vol. 46, no. 11, pp. 6671–6687, 1992, Erratum in Physical Review B, vol. 48, p. 4978, 1993. View at Publisher · View at Google Scholar
  46. J. P. Perdew, K. Burke, and Y. Wang, “Generalized gradient approximation for the exchange-correlation hole of a many-electron system,” Physical Review B, vol. 54, pp. 16533–16539, 1996, Erratum in Physical Review B, vol. 57, p. 14999, 1998. View at Publisher · View at Google Scholar
  47. J. P. Perdew, K. Burke, and M. Ernzerhof, “Generalized gradient approximation made simple,” Physical Review Letters, vol. 77, no. 18, pp. 3865–3868, 1996. View at Publisher · View at Google Scholar
  48. A. D. Becke, “Density-functional exchange-energy approximation with correct asymptotic behavior,” Physical Review A, vol. 38, no. 6, pp. 3098–3100, 1988. View at Publisher · View at Google Scholar
  49. A. D. Becke, “A new inhomogeneity parameter in density-functional theory,” Journal of Chemical Physics, vol. 109, no. 6, article 2092, 1998. View at Publisher · View at Google Scholar
  50. W. J. Hehre, L. Radom, P. V. R. Schleyer, and J. A. Pople, Ab Initio Molecular Orbital Theory, John Wiley & Sons, New York, NY, USA, 1986.
  51. M. J. Frisch, G. W. Trucks, H. B. Schlegel et al., “GAUSSIAN 09, Revision A. 02,” Gaussian, Wallingford, UK, 2009.
  52. P. Bultinck, X. Girones, and R. Carbó-Dorca, “Molecular quantum similarity: theory and applications,” Reviews in Computational Chemistry, vol. 21, 2005. View at Publisher · View at Google Scholar
  53. P. Bultinck and R. Carbó-Dorca, “A mathematical discussion on density and shape functions, vector semispaces and related questions,” Journal of Mathematical Chemistry, vol. 36, no. 2, pp. 191–200, 2004. View at Publisher · View at Google Scholar
  54. E. W. Weisstein, Encyclopedia of Mathematics, Chapman & Hall, London, UK, 2003.
  55. F. L. Hirshfeld, “Bonded-atom fragments for describing molecular charge densities,” Theoretica Chimica Acta, vol. 44, no. 2, pp. 129–138, 1977. View at Publisher · View at Google Scholar
  56. R. F. Nalewajski and R. G. Parr, “Information theory, atoms in molecules, and molecular similarity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 8879–8882, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. F. De Proft, R. Vivas-Reyes, A. Peeters, C. Van Alsenoy, and P. Geerlings, “Hirshfeld partitioning of the electron density: atomic dipoles and their relation with functional group properties,” Journal of Computational Chemistry, vol. 24, no. 4, pp. 463–469, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. P. G. Mezey, “The holographic electron density theorem and quantum similarity measures,” Molecular Physics, vol. 96, no. 2, pp. 169–178, 1999. View at Publisher · View at Google Scholar
  59. P. Constans and R. Carbo, “Atomic shell approximation: electron density fitting algorithm restricting coefficients to positive values,” Journal of Chemical Information and Computer Sciences, vol. 35, no. 6, pp. 1046–1053, 1995. View at Publisher · View at Google Scholar
  60. R. Carbó-Dorca, “Quantum similarity, volume functions and generalized Carbó indices,” Journal of Mathematical Chemistry, vol. 49, no. 9, pp. 2109–2115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. R. G. Parr and R. G. Pearson, “Absolute hardness: companion parameter to absolute electronegativity,” Journal of the American Chemical Society, vol. 105, no. 26, pp. 7512–7516, 1983. View at Google Scholar · View at Scopus
  62. R. G. Pearson, Chemical Hardness, Wiley-VCH, Weinheim, Germany, 1997.
  63. P. W. Ayers, “The physical basis of the hard/soft acid/base principle,” Faraday Discuss, vol. 135, pp. 161–190, 2007. View at Publisher · View at Google Scholar
  64. W. T. Yang and R. G. Parr, “Hardness, softness, and the fukui function in the electronic theory of metals and catalysis,” Proceedings of the National Academy of Sciences, vol. 82, pp. 6723–6726, 1985. View at Google Scholar
  65. A. K. Chandra and M. T. Nguyen, “Fukui function and local softness as reactivity descriptors,” in Chemical Reactivity Theory: A Density-Functional View, P. K. Chattaraj, Ed., p. 163, Taylor and Francis, New York, NY, USA, 2008. View at Google Scholar
  66. R. G. Parr and W. T. Yang, “Density functional approach to the frontier-electron theory of chemical reactivity,” Journal of the American Chemical Society, vol. 106, no. 4, pp. 4049–4050, 1984. View at Publisher · View at Google Scholar
  67. W. T. Yang, R. G. Parr, and R. Pucci, “Electron density, Kohn-Sham frontier orbitals, and Fukui functions,” Journal of Chemical Physics, vol. 81, no. 6, article 2862, 1984. View at Publisher · View at Google Scholar
  68. P. W. Ayers, W. T. Yang, and L. J. Bartolotti, “The Fukui function,” in Chemical Reactivity Theory: A Density Functional View, P. K. Chattaraj, Ed., p. 255, CRC Press, Boca Raton, Fla, USA, 2009. View at Google Scholar
  69. P. W. Ayers and M. Levy, “Perspective on ‘density functional approach to the frontier-electron theory of chemical reactivity’,” Theoretical Chemistry Accounts, vol. 103, no. 3-4, pp. 353–360, 2000. View at Publisher · View at Google Scholar
  70. K. Fukui, “Role of frontier orbitals in chemical reactions,” Science, vol. 217, pp. 747–754, 1982. View at Publisher · View at Google Scholar
  71. K. Fukui, T. Yonezawa, and H. Shingu, “A molecular orbital theory of reactivity in aromatic hydrocarbons,” The Journal of Chemical Physics, vol. 20, no. 4, pp. 722–725, 1952. View at Google Scholar · View at Scopus
  72. W. Yang and W. J. Mortier, “The use of global and local molecular parameters for the analysis of the gas-phase basicity of amines,” Journal of the American Chemical Society, vol. 108, no. 19, pp. 5708–5711, 1986. View at Publisher · View at Google Scholar
  73. A. D. McLean and G. S. Chandler, “Contracted Gaussian basis sets for molecular calculations. I. Second row atoms, Z=11-18,” The Journal of Chemical Physics, vol. 72, no. 10, pp. 5639–5648, 1980. View at Google Scholar · View at Scopus
  74. J. D. Barrow, The World within the World, chapter 3, Clarendon Press, Oxford, UK, 1988.
  75. G. Ucar, N. Gokhan, A. Yesilada, and A. A. Bilgin, “1-N thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases,” Neuroscience Letters, vol. 382, no. 3, pp. 327–331, 2005. View at Publisher · View at Google Scholar
  76. J. Moizeszowicz, Psicofarmacología Psicodinámica IV, Editorial Paidós, Buenos Aires, Argentina, 2000.
  77. W. Maruyama, M. Weinstock, M. B. H. Youdim, M. Nagai, and M. Naoi, “Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor,” Neuroscience Letters, vol. 341, no. 3, pp. 233–236, 2003. View at Publisher · View at Google Scholar
  78. T. Wilens and J. Biederman, “The stimulants,” Psychiatric Clinics of North America, vol. 15, no. 1, pp. 191–222, 1992. View at Google Scholar
  79. J. Sterling, Y. Herzig, T. Goren et al., “Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease,” Journal of Medicinal Chemistry, vol. 45, no. 24, pp. 5260–5279, 2002. View at Publisher · View at Google Scholar
  80. J. Sterling, A. Veinberg, D. Lerner et al., “(R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B,” Journal of Neural Transmission. Supplementa, vol. 52, pp. 301–305, 1998. View at Google Scholar
  81. E. Groner, Y. Ashani, D. Schorer-Apelbaum, J. Sterling, Y. Herzig, and M. Weinstock, “The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates,” Molecular Pharmacology, vol. 71, pp. 1610–1617, 2007. View at Publisher · View at Google Scholar
  82. A. Ordentlich, D. Barak, C. Kronman et al., “The architecture of human acetylcholinesterase active center probed by interactions with selected organophosphate inhibitors,” The Journal of Biological Chemistry, vol. 271, pp. 11953–11962, 1996. View at Publisher · View at Google Scholar
  83. M. A. Mena, E. G. Aguado, and J. G. De Yebenes, “Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method,” Acta Neurologica Scandinavica, vol. 69, no. 4, pp. 218–225, 1984. View at Publisher · View at Google Scholar